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Ventricular Assist Device Program Gains Prestigious Accreditation

A mandate in spring of 2009 by the Centers for Medicare & Medicaid Services (CMS) ruled that only CMS
certified centers would be eligible for reimbursement under Medicare for Ventricular Assist Device (VAD)
implantation. The CMS visited in July, and Jefferson was accredited as of August 11, 2009.
“This ensures that we are able to offer our first-rate care to the widest possible patient population,” says
Director of the Mechanical Circulatory Support Program Scott Silvestry, MD, “which is critical to our
mission as an academic medical center.”
During the CMS two-day visit, the auditor had what Dr. Silvestry describes as “an extremely favorable
impression of the multidisciplinary and collaborative spirit between the surgical and medical teams.” VAD
Coordinator Barbara Ebert, CRNP, is instrumental in managing care and assuring consistency across the
entire process. “These patients are extremely labor-intensive for caregivers—even more so after the LVAD
implant,” Dr. Silvestry notes. “They require constant monitoring and evaluation. Multidisciplinary
collaborative care is essential to good outcomes for all of our patients.” He adds that the Departments of
Pharmacy, Physical and Occupational Therapy, and Nursing, as well as students and fellows, have been
active collaborators, from the organ harvest process, to echocardiograms, to post-operative care in the
Intensive Care Unit (ICU) and Heart Failure Unit (at 5 West in the Gibbon Building).
VAD technology shows a significant and sustainable benefit for patients with heart failure who are not
candidates for a heart transplant. “The reality is that few patients are eligible for transplants,” Dr. Silvestry
says. For some patients who are candidates, the wait time may exceed 200 days. “VADs, including
experimental therapies such as the Jarvik Heart, can get them through this potentially long wait to
transplant.
Under the leadership of James Diehl, MD, Director of the Cardiothoracic Surgery Division, the Cardiac
Surgery Program as a whole has expanded greatly over the last six years and recruited several excellent
surgeons. Linda Bogar, MD, who was recruited five years ago, has now taken on a more senior role, which
includes mentoring the more junior surgeons as well as performing a number of heart transplants and

VAD procedures on her own. Benjamin Youdelman, MD, has now been on staff for two years. His practice,
based primarily at Einstein Hospital, specializes in endovascular and thoracic aortic surgery, valve repair
and replacement. Michel Haddad, MD, who joined Jefferson in 2008, is acting Director of the Surgical
Cardiac Care Unit. With a wealth of experience in intensive care of cardiac surgery patients, Dr. Haddad
splits his time between the operating room and the ICU. Finally, Hitoshi Hirose, MD, who recently
completed fellowships at Hahnemann and Jefferson, joined the faculty last August which further
increases the program’s capacity to care for complex cardiac patients.
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transplant. “The reality is that few patients
are eligible for transplants,” Dr. Silvestry
says. For some patients who are candidates,
the wait time may exceed 200 days. “VADs,
including experimental therapies such as
the Jarvik Heart, can get them through this
potentially long wait to transplant.
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Samuel D. Gross Professor and
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A new, civil day!
Recently the news has been filled
with examples of incivility and lack
of professionalism. In Congress the
representative from South Carolina shouted,
“You lie!” to President Obama. The final
matches of this year’s U.S. Open tennis
tournament were marred by inappropriate
behavior, both on the women’s and men’s
side. At a recent national awards telecast,
Kanye West interrupted the presentation to
the winner, Taylor Swift. Is civility dead?
Surveys of health care workers have pointed
out that incivility, and disruptive physician
behaviors, occur commonly. The resulting
hostile environment erodes cooperation and
commitment to high quality care. The Joint
Commission has asked hospitals to develop
formal and consistent ways of addressing
disruptive behavior. There are articles
in recent medical professional journals
encouraging us to be intolerant of disruptive
physician behavior.
Recently, Dr. John Moore brought to my
attention the fact that the Thomas Jefferson
University (TJU) Code of Conduct, and its
accompanying Honor Code, had not been
put in place for our faculty, but was in effect
for our medical students. I am pleased
to report that the Department of Surgery
unanimously approved the TJU Code of
Conduct and Honor Code and implemented
it as a departmental policy.
We feel strongly that disruptive behavior,
incivility, and unprofessional behavior,
should not be tolerated. We recognize that
faculty behaviors influence others, and we
wish to serve as positive role models. We
condone neither horizontal violence nor
vertical violence, and recognize the impact
of such behaviors on physical aspects of
living, self-esteem, and self-confidence.
My thanks go to Dr. Moore and the
faculty, residents, fellows, and staff of our
department. We have embarked upon a new
day. A new civil day!
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Program Director, Scott Silvestry, MD, along with Drs. Linda Bogar, Hitoshe Hirose, and
Michel Haddad (not shown) comprise the surgical component of Jefferson’s Mechanical
Circulatory Support Program.

Ventricular Assist Device
Program Gains Prestigious
Accreditation
A mandate in spring of 2009 by the
Centers for Medicare & Medicaid
Services (CMS) ruled that only CMScertified centers would be eligible
for reimbursement under Medicare
for Ventricular Assist Device (VAD)
implantation. The CMS visited in July,
and Jefferson was accredited as of
August 11, 2009.
“This ensures that we are able to offer
our first-rate care to the widest possible
patient population,” says Director of the
Mechanical Circulatory Support Program
Scott Silvestry, MD, “which is critical to our
mission as an academic medical center.”
During the CMS two-day visit, the auditor
had what Dr. Silvestry describes as “an
extremely favorable impression of the
multidisciplinary and collaborative spirit
between the surgical and medical teams.”
VAD Coordinator Barbara Ebert, CRNP,
is instrumental in managing care and
assuring consistency across the entire
process. “These patients are extremely
labor-intensive for caregivers—even more
so after the LVAD implant,” Dr. Silvestry
notes. “They require constant monitoring
and evaluation. Multidisciplinary
collaborative care is essential to good
outcomes for all of our patients.” He
adds that the Departments of Pharmacy,
Physical and Occupational Therapy,
and Nursing, as well as students and
fellows, have been active collaborators,
from the organ harvest process, to

echocardiograms, to post-operative care
in the Intensive Care Unit (ICU) and
Heart Failure Unit (at 5 West in the
Gibbon Building).
VAD technology shows a significant and
sustainable benefit for patients with heart
failure who are not candidates for a heart

Clinical Research Nurse Project Manager
How long have you been at Jefferson?
I’ve been here off and on since 1997,
first in the Department of Radiology. In
the interim I worked at Temple University
Hospital and Shriners Hospital for Children.
I’ve been in my current position since
March 2009, but previously served as the
research coordinator for the Division of
Vascular and Endovascular Surgery.

Under the leadership of James Diehl, MD,
Director of the Cardiothoracic Surgery
Division, the Cardiac Surgery Program as
a whole has expanded greatly over the last
six years and recruited several excellent
surgeons. Linda Bogar, MD, who was
recruited five years ago, has now taken
on a more senior role, which includes
mentoring the more junior surgeons as
well as performing a number of heart
transplants and VAD procedures on
her own. Benjamin Youdelman, MD,
has now been on staff for two years. His
practice, based primarily at Einstein
Hospital, specializes in endovascular and
thoracic aortic surgery, valve repair and
replacement. Michel Haddad, MD, who
joined Jefferson in 2008, is acting Director
of the Surgical Cardiac Care Unit. With
a wealth of experience in intensive care
of cardiac surgery patients, Dr. Haddad
splits his time between the operating room
and the ICU. Finally, Hitoshi Hirose,
MD, who recently completed fellowships
at Hahnemann and Jefferson, joined the
faculty last August which further increases
the program’s capacity to care for complex
cardiac patients.

What are the responsibilities of your
current role?

Anthony Holland, PhD, composer and professor, conducting radiofrequency experiments on
pancreatic cancer cells in a Division of Surgical Research laboratory at Jefferson

New Cancer Research Angle
from a Surprising Source
In medical research—like in all areas of
innovation—it is impossible to predict
where the next great idea might come
from. The Department of Surgery recently
hosted a researcher who is investigating
an unusual potential cancer treatment:
Anthony Holland, PhD, a renowned
composer who has conducted at Carnegie
Hall and has been teaching at Skidmore
College for 27 years.

Please Welcome
MEET OUR
SURGICAL INTERNS

Since early in his career, Dr. Holland has
been interested in physics and acoustics.
“Years ago I read a book [about] a
frequency machine that was capable
of destroying microorganisms if it was
tuned to just the right frequency.” This
made sense intuitively to Dr. Holland;
each semester he taught his students
to be careful about conditions that can
create sound that travels at a particular
wavelength, which can develop a
“resonant frequency.”

Jefferson surgeons are currently
assisted by an exceptional group
of categorical interns, half of
them Jefferson Medical College
graduates. These doctors, who
recently matched with Jefferson,
started on June 20, 2009 (l to r):
Katrina Harper, MD

Georgetown University
Kathleen Lamb, MD

Jefferson Medical College
Carrie Houssock, MD

Jefferson Medical College
Jose Munoz, MD

UMDNJ/New Jersey Medical School

On the Job

Dr. Holland had audited courses on
microbiology in the past. “I learned to use
microscopes and to grow and safely keep
bacteria—and later cancer cells—in an
incubator.” Dr. Holland was able to gather
the necessary electronic components
and build a frequency machine. For
fifteen months he ran test frequencies on
harmless, easy-to-obtain microorganisms
(paramecium and blepharisma).

Dr. Houssock, who was a preliminary intern last
year, is now joining the PGY2 class. We are also
pleased to welcome back another Jefferson
Medical College graduate, Erika Davis, MD, as a
preliminary intern in General Surgery.

Renee Tholey, MD

Jefferson Medical College
Konrad Sarosiek, MD

Drexel University
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“I began to try different frequencies, and
at first nothing happened. Then I tried
putting more than one frequency into
the organism simultaneously.” Then
a light bulb went on for Dr. Holland.
“If I added one additional frequency,
in a special relationship to the first
frequency, I’d be creating more power
and have a better chance at landing on
the frequency necessary to change the
organism,” Dr. Holland says. “When I
added the eleventh harmonic, I looked
through the microscope and discovered
that the microorganism had shattered.
It reminded me of how a crystal glass
shatters when a soprano hits just the
right note.”

I coordinate clinical trials for the Department
of Surgery and handle the administration
of Institutional Review Board submissions
and budgets for industry trials. My primary
responsibility is to provide support to the
faculty who are undertaking an increasing
number of clinical research projects in their
efforts to establish a more robust clinical
trial program in the department.
What is required to become certified as a
Clinical Research Coordinator?
The formal Certified Clinical Research
Coordinator (CCRC) certification by
the Association of Clinical Research
Professionals requires experience in
clinical practice, knowledge of Food and

the presentation, Dr. Holland invited him
to watch his video of the cells exploding.
After several minutes, Dr. Brody asked,
“Could you blow up cancer cells like
that?” Dr. Holland said, “I don’t know,
but I’d like to try.” Dr. Brody then
arranged Dr. Holland’s mini-sabbatical in
the Department of Surgery at Jefferson.

Jefferson has been
extremely open-minded
throughout this process,
which is the ultimate test
of a research institution

“Jefferson has been extremely openminded throughout this process,
which is the ultimate test of a research
institution,” says Dr. Holland. “I assumed
that physicians and other researchers
would think it was a nutty idea,” he
confesses. “But to the contrary—everyone
I encountered realized the potential. I
have never experienced such a wonderful
reception of new ideas in my entire
professional life.”

As luck would have it, in 2008, Dr.
Holland attended a Skidmore Alumni
Day presentation on pancreatic cancer
by his former student Jonathan Brody,
PhD, Assistant Professor in Jefferson’s
Division of Surgical Research. Following

“Dr. Holland is an extraordinary man,”
says Dr. Brody, who has been impressed
by his work since he was his student in
the 1990s. “and we need extraordinary
people working together from many
angles to fight this devastating disease.”

Drug Administration (FDA) regulations,
a comprehensive written exam, and
continuing education in clinical research
as well as nursing.
What does an average day
on the job look like?
It really varies almost daily. One day,
I might recruit patients to participate in
a particular study. In early August,
I supervised a study monitor’s four-day
visit for one of our ongoing industrysponsored trials. I also evaluate new studies
proposed to our surgeons to determine
their fiscal feasibility, if they are ethically
appropriate and whether we have the
appropriate patient population. Given the
range of responsibilities I’m juggling, a
critical part of my job is time management!

Preliminary results suggest that Dr.
Holland’s device causes changes in the
size and shape of pancreatic cancer cells.
“This reflects that we’re in the right
ballpark,” he says, “that the frequency
could affect cells as to destroy them.” Dr.
Holland was invited back to Jefferson in
August to repeat two key experiments,
and he reports that highly technical
quantitative analysis indicates some
promising results.
Dr. Holland is going on sabbatical from
Skidmore this January, and plans to
continue (and ultimately publish) his
research. “When people ask me what
kind of music I’m composing now,” he
says, “I tell them I’m writing music for
microorganisms and cancer cells. But
what makes this piece different, is that if
I do it right, it won’t be enjoyable to the
audience. It will do them in.”
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